Abstract
Chronic inflammation is characteristic of both HIV and aging (“inflammaging”) and may contribute to the accelerated aging observed in people living with HIV (PLWH). We examined whether three inflammation-related single-nucleotide polymorphisms (SNPs) were risk factors for accelerated aging and HIV-associated, non-AIDS (HANA) conditions among PLWH. We examined 155 postmortem cases with HIV (mean age = 47.3, 81% male, 68% self-reported White) from the National NeuroAIDS Tissue Consortium who had pre-mortem neurobehavioral/medical/virologic data and epigenomic data from occipital cortex tissue. Accelerated aging was measured according to the Epigenetic Clock; an aging biomarker based on DNA methylation levels. Past or current age-associated HANA conditions including cerebrovascular, liver and kidney disease, chronic obstructive pulmonary disease, cancer, and diabetes were determined via self-report. Epigenetic Aging Z-scores and likelihood of past/current HANA conditions were compared between major allele homozygotes and minor allele carriers for each SNP (IL-6 − 174G>C, IL-10 − 592C>A, TNF-α − 308 G>A) separately. Analyses were adjusted for relevant demographic/clinical factors. Epigenetic aging (e.g., higher Z-scores) was significantly greater in IL-6 C allele carriers (p = .002) and IL-10 CC homozygotes (p = .02) compared to other genotype groups. The likelihood of any past/current HANA condition did not differ by IL-10 genotype but was 3.36 times greater in IL-6 C allele carriers versus others (OR = 3.36, 95%CI = 1.09–10.34, p = .03). TNF-α genotype was not associated with epigenetic aging or HANA conditions. IL-6 and IL-10 SNPs may help to identify PLWH who are at high risk for accelerated aging. These insights into pathophysiological pathways may inform interventional approaches to treat rapid aging among PLWH.
Similar content being viewed by others
References
Albani D, Mazzuco S, Polito L, Batelli S, Biella G, Ongaro F, Gustafson DR, Antuono P, Gajo G, Durante E, Caberlotto L, Zanardo A, Siculi M, Gallucci M, Forloni G (2011) Insulin-like growth factor 1 receptor polymorphism rs2229765 and circulating interleukin-6 level affect male longevity in a population-based prospective study (Treviso Longeva--TRELONG). Aging Male 14(4):257–264. https://doi.org/10.3109/13685538.2011.607521
Altun B, Yilmaz R, Kahraman S, Gençtoy G, Arici M, Onalan O, Oto A, Hayran M, Bakkaloğlu M, Yasavul U, Turgan C (2005) Impact of cytokine gene polymorphism on cardiovascular risk in renal transplant recipients. Transpl Int 18:681–689. https://doi.org/10.1111/j.1432-2277.2005.00118.x
Alvarez V, Mata IF, Gonzalez P, Lahoz CH, Martinez C, Pena J, Guisasola LM, Coto E (2002) Association between the TNFalpha-308 A/G polymorphism and the onset-age of Alzheimer disease. Am J Med Genet 114:574–577. https://doi.org/10.1002/ajmg.10515
Antinori A, Arendt G, Becker JT, Brew BJ, Byrd DA, Cherner M, Clifford DB, Cinque P, Epstein LG, Goodkin K, Gisslen M, Grant I, Heaton RK, Joseph J, Marder K, Marra CM, McArthur JC, Nunn M, Price RW, Pulliam L, Robertson KR, Sacktor N, Valcour V, Wojna VE (2007) Updated research nosology for HIV-associated neurocognitive disorders. Neurology 69(18):1789–1799. https://doi.org/10.1212/01.WNL.0000287431.88658.8b
Barbieri M, Ferrucci L, Ragno E, Corsi A, Bandinelli S, Bonafè M, Olivieri F, Giovagnetti S, Franceschi C, Guralnik JM, Paolisso G (2003) Chronic inflammation and the effect of IGF-I on muscle strength and power in older persons. Am J Physiol Endocrinol Metab 284(3):E481–E487. https://doi.org/10.1152/ajpendo.00319.2002
Bonafè M, Olivieri F, Cavallone L, Giovagnetti S, Mayegiani F, Cardelli M, Pieri C, Marra M, Antonicelli R, Lisa R, Rizzo MR, Paolisso G, Monti D, Franceschi C (2001) A gender--dependent genetic predisposition to produce high levels of IL-6 is detrimental for longevity. Eur J Immunol 31(8):2357–2361. https://doi.org/10.1002/1521-4141(200108)31:8<2357::AID-IMMU2357>3.0.CO;2-X
Bruunsgaard H, Pedersen M, Pedersen BK (2001) Aging and proinflammatory cytokines. Curr Opin Hematol 8:131–136
Cederholm T, Persson M, Andersson P, Stenvinkel P, Nordfors L, Madden J, Vedin I, Wretlind B, Grimble RF, Palmblad J (2007) Polymorphisms in cytokine genes influence long-term survival differently in elderly male and female patients. J Intern Med 262(2):215–223
Centers for Disease Control and Prevention (2017) HIV surveillance report, 2016. vol 28, Available via https://www.cdcgov/hiv/library/reports/hiv-surveillancehtml. Accessed 2 Jan 2018
Christiansen L, Bathum L, Andersen-Ranberg K, Jeune B, Christensen K (2004) Modest implication of interleukin-6 promoter polymorphisms in longevity. Mech Ageing Dev 125(5):391–395. https://doi.org/10.1016/j.mad.2004.03.004
Clifford RL, Jones MJ, MacIsaac JL, McEwen LM, Goodman SJ, Mostafavi S, Kobor MS, Carlsten C (2017) Inhalation of diesel exhaust and allergen alters human bronchial epithelium DNA methylation. J Allergy Clin Immunol 139:112–121. https://doi.org/10.1016/j.jaci.2016.03.046
Cohen HJ, Pieper CF, Harris T, Rao KM, Currie MS (1997) The association of plasma IL-6 levels with functional disability in community-dwelling elderly. J Gerontol A Biol Sci Med Sci 52(4):M201–M208
Collins JS, Perry RT, Watson B Jr, Harrell LE, Acton RT, Blacker D, Albert MS, Tanzi RE, Bassett SS, McInnis MG, Campbell RD, Go RC (2000) Association of a haplotype for tumor necrosis factor in siblings with late-onset Alzheimer disease: the NIMH Alzheimer disease genetics initiative. Am J Med Genet 96:823–830
Culpan D, MacGowan SH, Ford JM, Nicoll JA, Griffin WS, Dewar D, Cairns NJ, Hughes A, Kehoe PG, Wilcock GK (2003) Tumour necrosis factor-alpha gene polymorphisms and Alzheimer’s disease. Neurosci Lett 350:61–65
Deeks SG (2011) HIV infection, inflammation, immunosenescence, and aging. Annu Rev Med 62:141–155. https://doi.org/10.1146/annurev-med-042909-093756
Deeks SG, Phillips AN (2009) HIV infection, antiretroviral treatment, ageing, and non-AIDS related morbidity. BMJ 338:a3172. https://doi.org/10.1136/bmj.a3172
Dunning MJ, Barbosa-Morais NL, Lynch AG, Tavaré S, Ritchie ME (2008) Statistical issues in the analysis of Illumina data. BMC Bioinformatics 9:85. https://doi.org/10.1186/1471-2105-9-85
Durand M, Chartrand-Lefebvre C, Baril JG, Trottier S, Trottier B, Harris M, Walmsley S, Conway B, Wong A, Routy JP, Kovacs C, MacPherson PA, Monteith KM, Mansour S, Thanassoulis G, Abrahamowicz M, Zhu Z, Tsoukas C, Ancuta P, Bernard N, Tremblay CL, Investigators of the Canadian HIV and aging cohort Study (2017) The Canadian HIV and aging cohort study - determinants of increased risk of cardiovascular diseases in HIV-infected individuals: rationale and study protocol. BMC Infect Dis 17(1):611. https://doi.org/10.1186/s12879-017-2692-2
Ershler WB, Sun WH, Binkley N, Gravenstein S, Volk MJ, Kamoske G, Klopp RG, Roecker EB, Daynes RA, Weindruch R (1993) Interleukin-6 and aging: blood levels and mononuclear cell production increase with advancing age and in vitro production is modifiable by dietary restriction. Lymphokine Cytokine Res 12(4):225–230
Fagiolo U, Cossarizza A, Scala E, Fanales-Belasio E, Ortolani C, Cozzi E, Monti D, Franceschi C, Paganelli R (1993) Increased cytokine production in mononuclear cells of healthy elderly people. Eur J Immunol 23(9):2375–2378. https://doi.org/10.1002/eji.1830230950
Ferrucci L, Harris TB, Guralnik JM, Tracy RP, Corti MC, Cohen HJ, Penninx B, Pahor M, Wallace R, Havlik RJ (1999) Serum IL-6 level and the development of disability in older persons. J Am Geriatr Soc 47(6):639–646
Fishman D, Faulds G, Jeffery R, Mohamed-Ali V, Yudkin JS, Humphries S, Woo P (1998) The effect of novel polymorphism in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest 102:1369–1376. https://doi.org/10.1172/JCI2629
Fragoso JM, Vallejo M, Alvarez-León E, Delgadillo H, Peña-Duque MA, Cardoso-Saldaña G, Posadas-Romero C, Martínez-Ríos MA, Vargas-Alarcón G (2011) Alleles and haplotypes of the interleukin 10 gene polymorphisms are associated with risk of developing acute coronary syndrome in Mexican patients. Cytokine 55(1):29–33. https://doi.org/10.1016/j.cyto.2011.03.021
Giovannini S, Onder G, Liperoti R, Russo A, Carter C, Capoluongo E, Pahor M, Bernabei R, Landi F (2011) Interleukin-6, C-reactive protein, and tumor necrosis factor-alpha as predictors of mortality in frail, community-living elderly individuals. J Am Geriatr Soc 59(9):1679–1685. https://doi.org/10.1111/j.1532-5415.2011.03570.x
Gross AM, Jaeger PA, Kreisberg JF, Licon K, Jepsen KL, Khosroheidari M, Morsey BM, Swindells S, Shen H, Ng CT, Flagg K, Chen D, Zhang K, Fox HS, Ideker T (2016) Methylome-wide analysis of chronic HIV infection reveals five-year increase in biological age and epigenetic targeting of HLA. Mol Cell 62(2):157–168. https://doi.org/10.1016/j.molcel.2016.03.019
Harris TB, Ferrucci L, Tracy RP, Corti MC, Wacholder S, Ettinger WH Jr, Heimovitz H, Cohen HJ, Wallace R (1999) Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly. Am J Med 106:506–512
Hermann SM, Richard S, Nicaud V, Mallet C, Arveiler D, Evans A, Ruidavets JB, Luc G, Bara L, Parra HJ, Poirier O, Cambien F (1998) Polymorphisms of the tumour necrosis factor-α gene, coronary heart disease and obesity. Eur J Clin Investig 28:59–66
Hoffmann SC, Stanley EM, Cox ED, DiMercurio BS, Koziol DE, Harlan DM, Kirk AD, Blair PJ (2002) Ethnicity greatly influences cytokine gene polymorphism distribution. Am J Transplant 2(6):560–567
Horvath S (2013) DNA methylation age of human tissues and cell types. Genome Biol 14(10):R115. https://doi.org/10.1186/gb-2013-14-10-r115
Horvath S, Levine AJ (2015) HIV-1 Infection accelerates age according to the epigenetic clock. J Infect Dis 212(10):1563–1573. https://doi.org/10.1093/infdis/jiv277
Hunt PW, Lee SA, Siedner MJ (2016) Immunologic biomarkers, morbidity, and mortality in treated HIV infection. J Infect Dis 214(suppl 2):S44–S50. https://doi.org/10.1093/infdis/jiw275
Hurme M, Lehtimäki T, Jylhä M, Karhunen PJ, Hervonen A (2005) Interleukin-6 -174G/C polymorphism and longevity: a follow-up study. Mech Ageing Dev 126(3):417–418. https://doi.org/10.1016/j.mad.2004.10.001
Jones SA (2005) Directing transition from innate to acquired immunity: defining a role for IL-6. J Immunol 175:3463–3468
Jones SA, Horiuchi S, Topley N, Yamamoto N, Fuller GM (2001) The soluble interleukin 6 receptor: mechanisms of production and implications in disease. FASEB J 15:43–58. https://doi.org/10.1096/fj.99-1003rev
Kawanishi S, Hiraku Y (2006) Oxidative and nitrative DNA damage as biomarker for carcinogenesis with special reference to inflammation. Antioxid Redox Signal 8(5–6):1047–1058
Kayaaltı Z, Sahiner L, Durakoğlugil ME, Söylemezoğlu T (2011) Distributions of interleukin-6 (IL-6) promoter and metallothionein 2A (MT2A) core promoter region gene polymorphisms and their associations with aging in Turkish population. Arch Gerontol Geriatr 53(3):354–358. https://doi.org/10.1016/j.archger.2011.01.001
Khabour OF, Barnawi JM (2010) Association of longevity with IL-10 −1082G/Aand TNF-−308G/A polymorphisms. Int J Immunogenet 37(4):293–298. https://doi.org/10.1111/j.1744-313X.2010.00925.x
Koch W, Kastrati A, Böttiger C, Mehilli J, von Beckerath N, Schömig A (2001) Interleukin-10 and tumor necrosis factor gene polymorphisms and risk of coronary artery disease and myocardial infarction. Atherosclerosis 159(1):137–144
Kochanek KD, Murphy S, Xu J, Arias E (2017) Mortality in the United States, 2016. NCHS Data Brief 293:1–8
Kroeger KM, Carville KS, Abraham LJ (1997) The −308 tumor necrosis factor alpha promoter polymorphism effects transcription. Mol Immunol 34:391–399
Lagathu C, Cossarizza A, Béréziat V, Nasi M, Capeau J, Pinti M (2017) Basic science and pathogenesis of ageing with HIV: potential mechanisms and biomarkers. AIDS 31(Suppl 2):S105–S119. https://doi.org/10.1097/QAD.0000000000001441
Lau A, Swinbank KM, Ahmed PS, Taylor DL, Jackson SP, Smith GCM, O'Connor MJ (2005) Suppression of HIV-1 infection by a small molecule inhibitor of the ATM kinase. Nat Cell Biol 7:493–500
Lio D, Scola L, Crivello A, Colonna-Romano G, Candore G, Bonafè M, Cavallone L, Franceschi C, Caruso C (2002) Gender-specific association between−1082 IL-10 promoter polymorphism and longevity. Genes Immun 3(1):30–33. https://doi.org/10.1038/sj.gene.6363827
Mallat Z, Besnard S, Duriez M, Deleuze V, Emmanuel F, Bureau MF, Soubrier F, Esposito B, Duez H, Fievet C, Staels B, Duverger N, Scherman D, Tedgui A (1999) Protective role of interleukin-10 in atherosclerosis. Circ Res 85:E17
Morgello S, Gelman BB, Kozlowski PB (2001) The National NeuroAIDS Tissue Consortium: a new paradigm in brain banking with an emphasis on infectious disease. Neuropathol Appl Neurobiol 27(4):326–335
Naicker DD, Werner L, Kormuth E, Passmore JA, Mlisana K, Karim SA, Ndung'u T, Acute Infection Study Team CAPRISA (2009) Interleukin-10 promoter polymorphisms influence HIV-1 susceptibility and primary HIV-1 pathogenesis. J Infect Dis 200:448–452. https://doi.org/10.1086/600072
Nasi M, De Biasi S, Gibellini L, Bianchini E, Pecorini S, Bacca V, Guaraldi G, Mussini C, Pinti M, Cossarizza A (2017) Ageing and inflammation in patients with HIV infection. Clin Exp Immunol 187(1):44–52. https://doi.org/10.1111/cei.12814
Naumova E, Mihaylova A, Ivanova M, Mihailova S (2004) Immunological markers contributing to successful aging in Bulgarians. Exp Gerontol 39(4):637–644. https://doi.org/10.1016/j.exger.2003.08.014
Neuhaus J, Jacobs DR Jr, Baker JV, Calmy A, Duprez D, La Rosa A, Kuller LH, Pett SL, Ristola M, Ross MJ, Shlipak MG, Tracy R, Neaton JD (2010) Markers of inflammation, coagulation, and renal function are elevated in adults with HIV infection. J Infect Dis 201:1788–1795. https://doi.org/10.1086/652749
Nixon DE, Landay AL (2010) Biomarkers of immune dysfunction in HIV. Curr Opin HIV AIDS 5(6):498–503. https://doi.org/10.1097/COH.0b013e32833ed6f4
Ohnishi S, Ma N, Thanan R, Pinlaor S, Hammam O, Murata M, Kawanishi S (2013) DNA damage in inflammation-related carcinogenesis and cancer stem cells. Oxidative Med Cell Longev 387014:1–9. https://doi.org/10.1155/2013/387014
Ohshima H, Tatemichi M, Sawa T (2003) Chemical basis of inflammation-induced carcinogenesis. Arch Biochem Biophys 417(1):3–11
Okayama N, Hamanaka Y, Suehiro Y, Nakamura J, Hinoda Y (2005) Association of interleukin-10 promoter single nucleotide polymorphisms−819T/C and −592A/C with aging. J Gerontol A Biol Sci Med Sci 60(12):1525–1529
Pathai S, Bajillan H, Landay AL, High KI (2014) Is HIV a model of accelerated or accentuated aging? J Gerontol A Biol Sci Med Sci 69:833–842. https://doi.org/10.1093/gerona/glt168
Peduzzi P, Concato J, Kemper E, Holford TR, Feinstein AR (1996) A simulation study of the number of events per variable in logistic regression analysis. J Clin Epidemiol 49(12):1373–1379
Pinderski-Oslund LJ, Hedrick CC, Olvera T, Hagenbaugh A, Territo M, Berliner JA, Fyfe AI (1999) Interleukin-10 blocks atherosclerotic events in vitro and in vivo. Arterioscler Thromb Vasc Biol 19:2847–2853
Pontillo A, Oshiro TM, Girardelli M, Kamada AJ, Crovella S, Duarte AJ (2012) Polymorphisms in inflammasome’ genes and susceptibility to HIV-1 infection. J Acquir Immune Defic Syndr 59:121–125. https://doi.org/10.1097/QAI.0b013e3182392ebe
Posadas-Sánchez R, Angeles-Martínez J, Pérez-Hernández N, Rodríguez-Pérez JM, López-Bautista F, Flores-Dominguez C, Fragoso JM, Posadas-Romero C, Vargas-Alarcón G (2018) The IL-10-1082 (rs1800896) G allele is associated with a decreased risk of developing premature coronary artery disease and some IL-10 polymorphisms were associated with clinical and metabolic parameters. The GEA study. Cytokine 106:12–18. https://doi.org/10.1016/j.cyto.2018.02.028
Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM (2001) C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 286(3):327–334
Rady PL, Matalon R, Grady J, Smith EM, Hudnall SD, Kellner LH, Nitowsky H, Tyring SK, Hughes TK (2004) Comprehensive analysis of genetic polymorphisms in the interleukin-10 promoter: implications for immune regulation in specific ethnic populations. Genet Test 8(2):194–203. https://doi.org/10.1089/gte.2004.8.194
Rezer JFP, Adefegha SA, Ecker A, Passos DF, Saccol RSP, Bertoldo TMD, Leal DBR (2018) Changes in inflammatory/cardiac markers of HIV positive patients. Microb Pathog 114:264–268. https://doi.org/10.1016/j.micpath.2017.11.045
Ross OA, Curran MD, Rea IM, Hyland P, Duggan O, Barnett CR, Annett K, Patterson C, Barnett YA, Middleton D (2003) HLA haplotypes and TNF polymorphism do not associate with longevity in the Irish. Mech Ageing Dev 124(4):563–567
Schindler R, Mancilla J, Endres S, Ghorbani R, Clark SC, Dinarello CA (1990) Correlations and interactions in the production of interleukin-6 (IL-6), IL-1, and tumor necrosis factor (TNF) in human mononuclear cells: IL-6 suppresses IL-1 and TNF. Blood 75:40–44
Seifart C, Dempfle A, Plagens A, Seifart U, Clostermann U, Müller B, Vogelmeier C, von Wichert P (2005) TNF-alpha-, TNF-beta-, IL-6-, and IL-10-promoter polymorphisms in patients with chronic obstructive pulmonary disease. Tissue Antigens 65(1):93–100. https://doi.org/10.1111/j.1399-0039.2005.00343.x
Singh T, Newman AB (2011) Inflammatory markers in population studies of aging. Ageing Res Rev 10(3):319–329. https://doi.org/10.1016/j.arr.2010.11.002
Smith DA, Irving SD, Sheldon J, Cole D, Kaski JC (2001) Serum levels of the anti-inflammatory cytokine interleukin-10 are decreased in patients with unstable angina. Circulation 104:46–749
So-Armah KA, Tate JP, Chang CH, Butt AA, Gerschenson M, Gibert CL, Leaf D, Rimland D, Rodriguez-Barradas MC, Budoff MJ, Samet JH, Kuller LH, Deeks SG, Crothers K, Tracy RP, Crane HM, Sajadi MM, Tindle HA, Justice AC, Freiberg MS, VACS Project Team (2016) Do biomarkers of inflammation, monocyte activation, and altered coagulation explain excess mortality between HIV infected and uninfected people? J Acquir Immune Defic Syndr 72(2):206–213. https://doi.org/10.1002/hep.29285
Sugimoto M, Furuta T, Shirai N, Nakamura A, Kajimura M, Sugimura H, Hishida A (2007) Effects of interleukin-10 gene polymorphism on the development of gastric cancer and peptic ulcer in Japanese subjects. J Gastroenterol Hepatol 9:1443–1449. https://doi.org/10.1111/j.1440-1746.2006.04613.x
Tachiwana H, Shimura M, Nakai-Murakami C, Tokunaga K, Takizawa Y, Sata T, Kurumizaka H, Ishizaka Y (2006) HIV-1 Vpr induces DNA double-strand breaks. Cancer Res 66:627–631
Teschendorff AE, Marabita F, Lechner M, Bartlett T, Tegner J, Gomez-Cabrero D, Beck S (2013) A beta-mixture quantile normalization method for correcting probe design bias in Illumina Infinium 450 k DNA methylation data. Bioinformatics 29(2):189–196. https://doi.org/10.1093/bioinformatics/bts680
Tilg H, Trehu E, Atkins MB, Dinarello CA, Mier JW (1994) Interleukin-6 (IL-6) as an anti-inflammatory cytokine: induction of circulating IL-1 receptor antagonist and soluble tumor necrosis factor receptor p55. Blood 83:113–118
Trompet S, Pons D, De Craen AJ, Slagboom P, Shepherd J, Blauw GJ, Murphy MB, Cobbe SM, Bollen EL, Buckley BM, Ford I, Hyland M, Gaw A, Macfarlane PW, Packard CJ, Norrie J, Perry IJ, Stott DJ, Sweeney BJ, Twomey C, Westendorp RG, Jukema JW (2007) Genetic variation in the interleukin-10 gene promoter and risk of coronary and cerebrovascular events: the PROSPER study. Ann N Y Acad Sci 1100:189–198. https://doi.org/10.1196/annals.1395.018
Turner DM, Williams DM, Sankaran D, Lazarus M, Sinnott PJ, Hutchinson IV (1997) An investigation of polymorphism in the interleukin—10 gene promoter. Eur J Immunogenet 24:1–8
Tuttolomondo A, Di Raimondo D, Forte GI, Casuccio A, Vaccarino L, Scola L, Pecoraro R, Serio A, Clemente G, Arnao V, Palmeri M, Misiano G, Lio D, Pinto A, Licata G (2012) Single nucleotide polymorphisms (SNPs) of pro-inflammatory/anti-inflammatory and thrombotic/fibrinolytic genes in patients with acute ischemic stroke in relation to TOAST subtype. Cytokine 58(3):398–405. https://doi.org/10.1016/j.cyto.2012.02.012
Vera JH, Guo Q, Cole JH, Boasso A, Greathead L, Kelleher P, Rabiner EA, Kalk N, Bishop C, Gunn RN, Matthews PM, Winston A (2016) Neuroinflammation in treated HIV-positive individuals: a TSPO PET study. Neurology 86:1425–1432. https://doi.org/10.1212/WNL.0000000000002485
Warriner AH, Burkholder GA, Overton ET (2014) HIV-related metabolic comorbidities in the current ART era. Infect Dis Clin N Am 28(3):457–476. https://doi.org/10.1016/j.idc.2014.05.003
Xing Z, Gauldie J, Cox G, Baumann H, Jordana M, Lei S-F, Achong K (1998) IL-6 is an anti-inflammatory cytokine required for controlling local or systemic acute inflammatory responses. J Clin Invest 101:311–320
Yu GI, Cho HC, Cho YK, Park HS, Yoon HJ, Kim HS, Nam CW, Kim YN, Kim KB, Ha E, Shin DH, Hur SH (2012) Association of promoter region single nucleotide polymorphisms at positions -819C/T and -592C/A of interleukin 10 gene with ischemic heart disease. Inflamm Res 61(8):899–905. https://doi.org/10.1007/s00011-012-0482-2
Yuen T, Brouillette MJ, Fellows LK, Ellis RJ, Letendre S, Heaton R, Mayo N, CHARTER group (2017) Personalized risk index for neurocognitive decline among people with well-controlled HIV Infection. J Acquir Immune Defic Syndr 76(1):48–54. https://doi.org/10.1097/QAI.0000000000001466
Zimmerman ES, Chen J, Andersen JL, Ardon O, DeHart JL, Blackett J, Choudhary SK, Camerini D, Nghiem P, Planelles V (2004) Human immunodeficiency virus type 1 Vpr-mediated G2 arrest requires rad17 and Hus1 and induces nuclear BRCA1 and γ-H2AX focus formation. Mol Cell Biol 24:9286–9294
Acknowledgments
The views expressed in this article are those of the authors and do not reflect the official policy or position of the Department of the Navy, Department of Defense, nor the United States Government. The authors thank the staff of the NNTC, particularly Ben Gouaux for their help with this project.
Funding
Primary funding was from R01MH096648 (MPIs: Levine and Moore). Additional funding was provided from R01DA030913 (MPIs: Levine and Horvath) as well as the following National Institute of Health awards [P30MH062512, N01 MH22005, HHSN271201000036C and HHSN271201000030C, U24 MH100928, T32DA031098]. This work was further supported by salary support for Dr. E.E. Sundermann from the Interdisciplinary Research Fellowship in NeuroAIDS [R25MH081482] and support for Ms. M.A. Hussain from the Training in Research on Addictions in Interdisciplinary NeuroAIDS (TRAIN; T32DA031098).
Author information
Authors and Affiliations
Consortia
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflicts of interest.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
ESM 1
(DOCX 13 kb)
Rights and permissions
About this article
Cite this article
Sundermann, E.E., Hussain, M.A., Moore, D.J. et al. Inflammation-related genes are associated with epigenetic aging in HIV. J. Neurovirol. 25, 853–865 (2019). https://doi.org/10.1007/s13365-019-00777-4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13365-019-00777-4